Synthesis, cytotoxicity assessment and molecular docking of novel thienyl-pyrazoles as VEGFR2 Inhibitors.

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Development and assessment of novel pyrazole–thiadiazol hybrid derivatives as VEGFR-2 inhibitors: design, synthesis, anticancer activity evaluation, molecular docking, and molecular dynamics simulation2024 · 2 citations
2. 2New 5-(pyridin-3-yl)-1,3,4-oxadiazoles derivatives as VEGFR2 inhibitors: in silico study, synthesis, and cytotoxicity evaluation2026 · 1 citations
3. 3Synthesis, anticancer properties, and molecular modeling of novel thiazolyl-pyrazolone derivatives conjugated with tetrahydronaphthalene as anticancer agents with potential VEGFR-2 inhibition activity2024 · 1 citations
4. 4Design, Synthesis, In Vitro Biological Evaluation, and In Silico Studies of Novel Imidazo[4,5‐ b ]Pyridine‐Acrylonitrile‐Based Derivatives as VEGFR‐2 Inhibitors Against Breast Cancer and Hepatocellular Carcinoma2026
5. 5Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment2025 · 2 citations